These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Discovery of two cyanobacterial phenylalanine ammonia lyases: kinetic and structural characterization. Moffitt MC; Louie GV; Bowman ME; Pence J; Noel JP; Moore BS Biochemistry; 2007 Jan; 46(4):1004-12. PubMed ID: 17240984 [TBL] [Abstract][Full Text] [Related]
6. Engineering and kinetic stabilization of the therapeutic enzyme Anabeana variabilis phenylalanine ammonia lyase. Jaliani HZ; Farajnia S; Mohammadi SA; Barzegar A; Talebi S Appl Biochem Biotechnol; 2013 Dec; 171(7):1805-18. PubMed ID: 23999738 [TBL] [Abstract][Full Text] [Related]
7. Preclinical evaluation of multiple species of PEGylated recombinant phenylalanine ammonia lyase for the treatment of phenylketonuria. Sarkissian CN; Gámez A; Wang L; Charbonneau M; Fitzpatrick P; Lemontt JF; Zhao B; Vellard M; Bell SM; Henschell C; Lambert A; Tsuruda L; Stevens RC; Scriver CR Proc Natl Acad Sci U S A; 2008 Dec; 105(52):20894-9. PubMed ID: 19095795 [TBL] [Abstract][Full Text] [Related]
8. Converting an injectable protein therapeutic into an oral form: phenylalanine ammonia lyase for phenylketonuria. Kang TS; Wang L; Sarkissian CN; Gámez A; Scriver CR; Stevens RC Mol Genet Metab; 2010 Jan; 99(1):4-9. PubMed ID: 19793667 [TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of a sterically robust phenylalanine ammonia-lyase among 481 natural isoforms through association of in silico and in vitro studies. Rahmatabadi SS; Sadeghian I; Ghasemi Y; Sakhteman A; Hemmati S Enzyme Microb Technol; 2019 Mar; 122():36-54. PubMed ID: 30638507 [TBL] [Abstract][Full Text] [Related]
10. Formulation and PEGylation optimization of the therapeutic PEGylated phenylalanine ammonia lyase for the treatment of phenylketonuria. Bell SM; Wendt DJ; Zhang Y; Taylor TW; Long S; Tsuruda L; Zhao B; Laipis P; Fitzpatrick PA PLoS One; 2017; 12(3):e0173269. PubMed ID: 28282402 [TBL] [Abstract][Full Text] [Related]
11. Cross-linked enzyme aggregates of phenylalanine ammonia lyase: novel biocatalysts for synthesis of L-phenylalanine. Cui JD; Zhang S; Sun LM Appl Biochem Biotechnol; 2012 Jun; 167(4):835-44. PubMed ID: 22622644 [TBL] [Abstract][Full Text] [Related]
13. One-Pot Enzymatic Synthesis of D-Arylalanines Using Phenylalanine Ammonia Lyase and L-Amino Acid Deaminase. Zhu L; Feng G; Ge F; Song P; Wang T; Liu Y; Tao Y; Zhou Z Appl Biochem Biotechnol; 2019 Jan; 187(1):75-89. PubMed ID: 29882193 [TBL] [Abstract][Full Text] [Related]
14. Alternative therapies to address the unmet medical needs of patients with phenylketonuria. Blau N; Longo N Expert Opin Pharmacother; 2015 Apr; 16(6):791-800. PubMed ID: 25660215 [TBL] [Abstract][Full Text] [Related]
17. The essential tyrosine-containing loop conformation and the role of the C-terminal multi-helix region in eukaryotic phenylalanine ammonia-lyases. Pilbák S; Tomin A; Rétey J; Poppe L FEBS J; 2006 Mar; 273(5):1004-19. PubMed ID: 16478474 [TBL] [Abstract][Full Text] [Related]
18. A Silk-Based Platform to Stabilize Phenylalanine Ammonia-lyase for Orally Administered Enzyme Replacement Therapy. d'Amone L; Trivedi VD; Nair NU; Omenetto FG Mol Pharm; 2022 Dec; 19(12):4625-4630. PubMed ID: 35862031 [TBL] [Abstract][Full Text] [Related]
19. Synthesis of D- and L-phenylalanine derivatives by phenylalanine ammonia lyases: a multienzymatic cascade process. Parmeggiani F; Lovelock SL; Weise NJ; Ahmed ST; Turner NJ Angew Chem Int Ed Engl; 2015 Apr; 54(15):4608-11. PubMed ID: 25728350 [TBL] [Abstract][Full Text] [Related]
20. Structure-based chemical modification strategy for enzyme replacement treatment of phenylketonuria. Wang L; Gamez A; Sarkissian CN; Straub M; Patch MG; Han GW; Striepeke S; Fitzpatrick P; Scriver CR; Stevens RC Mol Genet Metab; 2005; 86(1-2):134-40. PubMed ID: 16006165 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]